A carregar...
Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma
Despite the availability of new therapies that have led to improved outcomes for patients with multiple myeloma, most patients will eventually relapse. With triplet and even quadruplet combination therapies becoming standard in the first and second line, many patients will have few treatment options...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601491/ https://ncbi.nlm.nih.gov/pubmed/32992506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9103120 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|